Cargando…

Immunopathogenesis of Human Sporotrichosis: What We Already Know

Sporotrichosis is a subacute/chronic mycosis caused by dimorphic fungus of the genus Sporothrix. This mycosis may affect both human and domestic animals and in the last few years, the geographic dispersion and increase of sporotrichosis worldwide has been observed. The occurrence of cases related to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conceição-Silva, Fatima, Morgado, Fernanda Nazaré
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162489/ https://www.ncbi.nlm.nih.gov/pubmed/30065160 http://dx.doi.org/10.3390/jof4030089

Ejemplares similares

COVID-19 and the gastrointestinal tract: what do we already know?
por: de Almeida, Joana Ferro Machado, et al.
Publicado: (2020)

What we already know about rhubarb: a comprehensive review
por: Xiang, Hong, et al.
Publicado: (2020)

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
por: Shahgolzari, Mehdi, et al.
Publicado: (2021)

Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
por: Baj, Jacek, et al.
Publicado: (2022)

Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
por: Rudnicka-Drożak, Ewa, et al.
Publicado: (2023)

Preventing breast cancer now by acting on what we already know
por: Colditz, Graham A, et al.
Publicado: (2015)

Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: What We Already Know
por: Obeidat, Adham E, et al.
Publicado: (2022)

What we learned from STEP that we didn't already know from SPRINT
por: Modesti, Pietro Amedeo
Publicado: (2021)

The pathology behind glaucoma: what we already know using omics technologies
por: May, Caroline, et al.
Publicado: (2023)

Reducing Racial Inequities in Health: Using What We Already Know to Take Action
por: Williams, David R., et al.
Publicado: (2019)

Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features—What Do We Already Know?
por: Miądlikowska, Ewa, et al.
Publicado: (2021)

Ultra-processed foods and human health: What do we already know and what will further research tell us?
por: Srour, Bernard, et al.
Publicado: (2021)

Severe COVID-19: what have we learned with the immunopathogenesis?
por: Bordallo, Bruno, et al.
Publicado: (2020)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Plastic Interactions with Pollutants and Consequences to Aquatic Ecosystems: What We Know and What We Do Not Know
por: Cássio, Fernanda, et al.
Publicado: (2022)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Why We Already Know that Antihydrogen is Almost Certainly NOT Going to Fall "Up"
por: Menary, Scott
Publicado: (2012)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

Membrane fission by dynamin: what we know and what we need to know
por: Antonny, Bruno, et al.
Publicado: (2016)

Pneumonia in Bhutanese children: what we know, and what we need to know
por: Jullien, Sophie, et al.
Publicado: (2020)

Impacts of Neonicotinoids on Molluscs: What We Know and What We Need to Know
por: Ewere, Endurance E, et al.
Publicado: (2021)

How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
por: Lima-Junior, Josué da Costa, et al.
Publicado: (2017)

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
por: Kaya, Gürkan, et al.
Publicado: (2018)

Human Extraintestinal Sarcocystosis: What We Know, and What We don’t Know
por: Harris, V. C., et al.
Publicado: (2015)

Human metapneumovirus - what we know now
por: Shafagati, Nazly, et al.
Publicado: (2018)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

Plant hormone transporters: what we know and what we would like to know
por: Park, Jiyoung, et al.
Publicado: (2017)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ketamine plus Alcohol: What We Know and What We Can Expect about This
por: Kobayashi, Natalia Harumi Correa, et al.
Publicado: (2022)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

ECLS-associated infections in adults: what we know and what we don’t yet know
por: Abrams, Darryl, et al.
Publicado: (2019)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn
por: Augusto, Ronaldo de Carvalho, et al.
Publicado: (2018)

Alveolar epithelial and endothelial cell apoptosis in emphysema: What we know and what we need to know
por: Morissette, Mathieu C, et al.
Publicado: (2009)

High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
por: Üçeyler, Nurcan, et al.
Publicado: (2014)

Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
por: Kerensky, Todd, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9r8k5beikqb11pmmnhc4n8cskl